The launch of the new automatic immunofluorescence microscope EUROPattern Microscope Live is the final step of a development project which was first initiated in 2016 by EUROIMMUN’s founder and former CEO Prof Winfried Stöcker. He had the idea of a…
Read more
Press Release CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19. EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization…
Read more
Press ReleaseJena / Lübeck (GER) - Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN, a P…
Press ReleaseEUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope,…
Press ReleaseNovel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progressionEUROIMMUN, a…
Anti-SARS-CoV-2 antibody standard preparation from the WHO now availableSince end of December 2020, the first international reference material, “First WHO Int…
Learning from the past to create the laboratory of the futureWith EUROLabOffice 4.0 the successful EUROIMMUN laboratory management software enters into its four…
The launch of the new automatic immunofluorescence microscope EUROPattern Microscope Live is the final step of a development project which was first initiated i…